Multivalent hyaluronic acid bioconjugates improve sFlt-1 activity in vitro.

about

sFlt Multivalent Conjugates Inhibit Angiogenesis and Improve Half-Life In Vivo Biopolymer Molecular Weight Can Modulate the Wound Healing Efficacy of Multivalent Sonic Hedgehog-Hyaluronic Acid Conjugates.

P2860

Q28552652-40B8D5CE-15A2-4C02-B1E9-043627F52DC0 Q46519314-2C26C45A-B587-46DF-983A-0BA3DB61AD09

P2860

Multivalent hyaluronic acid bioconjugates improve sFlt-1 activity in vitro.

Item

http://www.wikidata.org/entity/Q35991894

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Multivalent hyaluronic acid bioconjugates improve sFlt-1 activity in vitro.

@ast

Multivalent hyaluronic acid bioconjugates improve sFlt-1 activity in vitro.

@en

type

Item

label

Multivalent hyaluronic acid bioconjugates improve sFlt-1 activity in vitro.

@ast

Multivalent hyaluronic acid bioconjugates improve sFlt-1 activity in vitro.

@en

prefLabel

Multivalent hyaluronic acid bioconjugates improve sFlt-1 activity in vitro.

@ast

Multivalent hyaluronic acid bioconjugates improve sFlt-1 activity in vitro.

@en

P1476

Multivalent hyaluronic acid bioconjugates improve sFlt-1 activity in vitro.

@en

P2093

Aline Zbinden

http://www.w3.org/2001/XMLSchema#string

Amit K Jha

http://www.w3.org/2001/XMLSchema#string

David V Schaffer

http://www.w3.org/2001/XMLSchema#string

Deepika Bhatnagar

http://www.w3.org/2001/XMLSchema#string

Eda I Altiok

http://www.w3.org/2001/XMLSchema#string

Felicia L Svedlund

http://www.w3.org/2001/XMLSchema#string

Jorge L Santiago-Ortiz

http://www.w3.org/2001/XMLSchema#string

Kevin E Healy

http://www.w3.org/2001/XMLSchema#string

Wesley M Jackson

http://www.w3.org/2001/XMLSchema#string

P2860

Theoretical analysis of fluorescence photobleaching recovery experiments.

Retinopathy in diabetes

Peptide and protein PEGylation: a review of problems and solutions

PEGylation, successful approach to drug delivery

Ocular drug delivery.

Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.

VEGF localisation in diabetic retinopathy.

A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema

Novel drug delivery systems for retinal diseases. A review.

Anti-Flt1 peptide - hyaluronate conjugate for the treatment of retinal neovascularization and diabetic retinopathy.

P304

95-105

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BIOMATERIALS.2016.03.017

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Peter Loskill

P577

2016-03-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27086270

http://www.w3.org/2001/XMLSchema#string

P932

5688241

http://www.w3.org/2001/XMLSchema#string

Multivalent hyaluronic acid bioconjugates improve sFlt-1 activity in vitro.

about

P2860

P2860

Multivalent hyaluronic acid bioconjugates improve sFlt-1 activity in vitro.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932